⌘K

Home/Filings/4/0001104659-24-001491

4//SEC Filing

Giraudo Bryan 4

Accession 0001104659-24-001491

CIK 0001377121other

View on SEC.gov Company Profile

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 8:10 PM ET

Size

5.7 KB

Accession

0001104659-24-001491

Insider Transaction Report

Form 4

Period: 2024-01-02

Protagonist Therapeutics, IncPTGX

Director

Transactions

Award
Stock Option (right to buy)
2024-01-02+25,700→ 25,700 total
Exercise: $23.42Exp: 2034-01-02→ Common Stock (25,700 underlying)

Footnotes (1)

[F1]The stock option vests in 12 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Documents

1 file

4
tm241954-3_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Protagonist Therapeutics, Inc

CIK 0001377121

Entity typeother

Related Parties

1

filerCIK 0001740847

Filing Metadata

Form type: 4
Filed: Jan 3, 7:00 PM ET
Accepted: Jan 4, 8:10 PM ET
Size: 5.7 KB

View on SEC.gov